Skip to main content
Clinical Trials/NCT05620108
NCT05620108CompletedNot Applicable

Intubating Conditions at Various Levels of Neuromuscular Blockade

Mayo Clinic1 site in 1 country170 target enrollmentStarted: November 28, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
170
Locations
1
Primary Endpoint
Number of Subjects With Optimal Intubating Conditions

Study Overview

Brief Summary

The purpose of this research is to learn about the difference in the endotracheal intubation condition (ease of using a device to view vocal cords, position of vocal cords, and patient's reaction to endotracheal tube insertion) and determining the appropriate time to perform the intubation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients willing to participate and provide an informed consent.
  • •Patients undergoing elective surgical procedures that require use of NMBA agents (rocuronium) administered intraoperatively.

Exclusion Criteria

  • •Patients with disorders, such as stroke, carpal tunnel syndrome, broken wrist with nerve damage, Dupuytren contracture, or any similar wrist injury.
  • •Patients with systemic neuromuscular diseases such as myasthenia gravis.
  • •Patients with significant organ dysfunction that can significantly affect pharmacokinetics of neuromuscular blocking and reversal agents; i.e., severe renal impairment or end-stage liver disease.
  • •Patients having surgery that would involve prepping the arm into the sterile field.
  • •Patients receiving a rapid sequence induction.

Arms & Interventions

Intubation at TOFC=1

Experimental

Subjects scheduled for an elective surgical procedure will have endotracheal intubation performed when muscles are almost relaxed and monitoring shows only a single count of muscle twitch (in response to a monitor that assesses muscle relaxation)

Intervention: Endotracheal Intubation at TOFC=1 (Procedure)

Intubation 2 minutes after rocuronium administration

Active Comparator

Subjects scheduled for an elective surgical procedure will have endotracheal intubation performed 2 minutes after the anesthesia provider gives muscle relaxing medication

Intervention: Endotracheal Intubation 2 minutes after rocuronium administration (Procedure)

Outcomes

Primary Outcomes

Number of Subjects With Optimal Intubating Conditions

Time Frame: Approximately 15 minutes after intubation

The number of subjects who had optimal intubating conditions (total composite score of 3) will be evaluated by the healthcare providers using a scale that includes 3 variables (ease of laryngoscopy, vocal cord position, and reaction to tracheal tube insertion) with 3 response options per each evaluation. The composite score (1-3) will be used, with the lowest total score of 3 correlating with optimal intubating conditions and the highest score of 9 representing the worse possible intubating conditions.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

J. Ross Renew, M.D.

Principal Investigator

Mayo Clinic

Study Sites (1)

Loading locations...

Similar Trials